BIOAGE LABS INC (BIOA:NASDAQ)
$9.84 -0.27 (-2.6706%)
Analysed BIOAGE LABS INC (BIOA:NASDAQ) News Sources
Earnings Update: Here's Why Analysts Just Lifted Their BioAge Labs, Inc. (NASDAQ:BIOA) Price Target To US$53.33
13-05-2026
yahoo.com
This CoinShares Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Wednesday
13-05-2026
yahoo.com
BioAge Labs to Present at Upcoming Investor Conferences
22-05-2026
yahoo.com
BioAge Labs Eyes Key BGE-102 Readouts in Heart Risk and Diabetic Eye Disease
06-06-2026
marketbeat.com
BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk
16-06-2026
yahoo.com
BioAge Labs (BIOA) Is Up 14.2% After Starting Phase 2 Trial Of Oral NLRP3 Inhibitor
25-06-2026
yahoo.com
Is BioAge Labs, Inc. (BIOA) Stock Positioned for Growth With New Phase 2 Cardiovascular Study Initiation?
30-06-2026
yahoo.com
BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection?
31-07-2026
stocktwits.com
BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates
05-08-2026
yahoo.com
BioAge Labs, Inc. (BIOA) Reports Q2 Loss, Beats Revenue Estimates
06-08-2026
yahoo.com
What is the current price of BIOAGE LABS INC (BIOA:NASDAQ)?
The current price of BIOAGE LABS INC (BIOA:NASDAQ) is $9.84.
BIOAGE LABS INC (BIOA:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOAGE LABS INC (BIOA:NASDAQ) since the previous trading day is $-0.27.
BIOAGE LABS INC (BIOA:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOAGE LABS INC (BIOA:NASDAQ) since the previous trading day is -2.6706%.
What is the most recent average sentiment score for BIOAGE LABS INC (BIOA:NASDAQ)?
The most recent average sentiment score for BIOAGE LABS INC (BIOA:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for BIOAGE LABS INC (BIOA:NASDAQ)?
The most recent sentiment for BIOAGE LABS INC (BIOA:NASDAQ) is .
SEC-8K** Filing Available For BIOAGE LABS INC (BIOA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.